KalVista Pharmaceuticals, Inc. (KALV) Social Stream
KALVISTA PHARMACEUTICALS INC (KALV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering KALVISTA PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 7 | $61 | $45 | $51.714 | $12.13 | 326.33% |
| 2022-01-20 | 6 | $55 | $45 | $50 | $12.13 | 312.2% |
| 2022-03-08 | 7 | $55 | $45 | $50 | $12.13 | 312.2% |
| 2022-03-11 | 7 | $55 | $33 | $47.571 | $12.13 | 292.18% |
| 2022-06-08 | 6 | $51 | $32 | $42.666 | $12.13 | 251.74% |
| 2022-09-09 | 6 | $48 | $32 | $40 | $12.13 | 229.76% |
| 2022-10-04 | 6 | $48 | $20 | $32.833 | $12.13 | 170.68% |
| 2022-12-13 | 6 | $30 | $14 | $21.833 | $12.13 | 79.99% |
| 2023-02-03 | 6 | $27 | $14 | $20.166 | $12.13 | 66.25% |
| 2023-03-10 | 6 | $24 | $14 | $19.666 | $12.13 | 62.13% |
| 2023-05-16 | 5 | $24 | $14 | $19.333 | $12.13 | 59.38% |
| 2023-07-11 | 5 | $26 | $14 | $19.666 | $12.13 | 62.13% |
| 2023-07-12 | 5 | $26 | $16 | $20.666 | $12.13 | 70.37% |
| 2023-09-08 | 6 | $26 | $16 | $20.666 | $12.13 | 70.37% |
| 2023-12-07 | 6 | $26 | $16 | $21 | $12.13 | 73.12% |
| 2023-12-17 | 6 | $26 | $16 | $20.8 | $12.13 | 71.48% |
The Trend in the Analyst Price Target
Over the past 43 months, KALV's average price target has gone down $5.91.
Over the past 45 weeks, KALV's average upside potential has been 123.37%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 6 | 24 | 14 | 19.333 | 6.96 | 177.77% |
| 2023-05-16 | 5 | 24 | 14 | 19.333 | 10.05 | 92.37% |
| 2023-07-10 | 5 | 26 | 14 | 19.666 | 10.47 | 87.83% |
| 2023-12-07 | 6 | 26 | 16 | 20.800 | 8.97 | 131.88% |
| 2023-12-17 | 6 | 26 | 16 | 20.800 | 10.68 | 94.76% |
KALV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.17 | 5 | 1 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
KALV's average broker recommendation rating improved by 0 over the prior 14 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- KALVISTA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1770.76% of all US stocks.
- KALVISTA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 598.94% of all US stocks.
- KALV has a higher average analyst price target than 1525.66% of stocks in the small market cap category.
- KALV has a lower variance in analysts' estimates than -631.71% of Pharmaceutical Products stocks.
Stocks similar to KALVISTA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are XBIT, GLYC, and TRVN.
View All Top Stocks by Price Target
What is the outlook for KALV? Use POWR Ratings for clearer insight into price direction.